Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
150.71B | 151.16B | 149.17B | 142.65B | 134.09B | 146.73B | Gross Profit |
32.33B | 33.30B | 29.54B | 31.55B | 26.18B | 26.80B | EBIT |
12.67B | 13.53B | 10.23B | 13.81B | 9.93B | 10.47B | EBITDA |
15.65B | 16.88B | 14.23B | 14.95B | 10.89B | 11.46B | Net Income Common Stockholders |
11.05B | 10.39B | 8.75B | 9.62B | 7.43B | 7.53B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
39.87B | 39.43B | 45.34B | 65.24B | 42.98B | 44.42B | Total Assets |
178.71B | 190.92B | 191.18B | 179.69B | 174.53B | 177.74B | Total Debt |
1.11B | 12.09B | 753.00M | 220.00M | 300.00M | 5.68B | Net Debt |
-38.77B | -27.34B | -44.58B | -65.02B | -42.68B | -38.74B | Total Liabilities |
68.92B | 81.35B | 80.18B | 78.52B | 80.18B | 87.19B | Stockholders Equity |
109.04B | 108.73B | 110.34B | 100.60B | 93.91B | 90.14B |
Cash Flow | Free Cash Flow | ||||
0.00 | -6.37B | -17.73B | 26.28B | 7.43B | -4.03B | Operating Cash Flow |
0.00 | -4.07B | -12.22B | 32.19B | 9.00B | -1.68B | Investing Cash Flow |
0.00 | 1.26B | -8.44B | -5.60B | -2.39B | -2.05B | Financing Cash Flow |
0.00 | 938.00M | -3.38B | -4.28B | -9.11B | 1.90B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥78.87B | 13.93 | 8.79% | 2.38% | 8.17% | -0.36% | |
77 Outperform | ¥163.14B | 7.29 | 2.40% | 9.84% | 16.55% | ||
76 Outperform | ¥596.96B | 29.40 | 6.03% | 1.73% | 6.25% | -30.43% | |
76 Outperform | ¥87.74B | 13.36 | 5.02% | 12.10% | 148.39% | ||
75 Outperform | ¥364.82B | 15.13 | 2.24% | 8.59% | 39.41% | ||
71 Outperform | $157.24B | 15.01 | 9.36% | 0.03% | 1.34% | 20.86% | |
66 Neutral | $4.47B | 12.22 | 5.40% | 3.65% | 4.14% | -12.00% |